Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor Conferences

CAMBRIDGE, Mass., Sept. 18  /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals Incorporated (Nasdaq GS: VRTX) will webcast corporate presentations at Merrill Lynch's Global Pharmaceutical, Biotech and Medtech Conference on September 21, 2006 and at the UBS Global Life Sciences Conference on September 26, 2006.

Ian Smith, Executive Vice President and Chief Financial Officer of Vertex, will present at the Merrill Lynch Conference.  The presentation and discussion will be conducted on Thursday, September 21, 2006 at 10:40 a.m. BST (5:40 a.m. EDT).

Joshua Boger, Ph.D., President and Chief Executive Officer of Vertex, will present at the UBS Global Life Sciences Conference on Tuesday, September 26, 2006 at 1:00 p.m. EDT.

The presentations will be webcast live and may be accessed by visiting the Vertex website at http://www.vrtx.com/.  A replay of the webcasts will also be available on the Company's website for two weeks following the presentations. To access the webcasts, go to Vertex's website and select the desired presentation from the 'Events Calendar.'  To ensure a timely connection, it is recommended that users register at least 15 minutes prior to the scheduled webcast.

About Vertex

Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company's strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex's product pipeline is focused on viral diseases, inflammation, autoimmune diseases, cancer, pain and bacterial infection. Vertex co-discovered the HIV protease inhibitor, Lexiva, with GlaxoSmithKline.

Lexiva is a registered trademark of the GlaxoSmithKline group of companies.

  Vertex's press releases are available at http://www.vrtx.com/.

  Vertex Contact:
  Lora Pike, Manager, Investor Relations, [phone]


DATASOURCE: Vertex Pharmaceuticals Incorporated



CONTACT:  Lora Pike, Manager, Investor Relations of Vertex

Pharmaceuticals Incorporated, [phone] 



Web site:  http://www.vrtx.com/



Company News On-Call:  http://www.prnewswire.com/comp/938395.html

Copyright